DAX23.214 +0,5%Est505.520 +0,1%MSCI World4.343 -0,1%Top 10 Crypto11,67 -0,4%Nas22.273 +0,9%Bitcoin74.412 -1,3%Euro1,1545 +0,3%Öl62,69 +0,3%Gold4.079 +0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Bayer BAY001 NVIDIA 918422 RENK RENK73 DroneShield A2DMAA Siemens Energy ENER6Y Novo Nordisk A3EU6F Lufthansa 823212 Deutsche Telekom 555750 HENSOLDT HAG000 BASF BASF11 TKMS thyssenkrupp Marine Systems TKMS00 Alphabet A (ex Google) A14Y6F Amazon 906866 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Zinshoffnungen: DAX zieht an -- DroneShield im Visier von Shortsellern -- Alphabet, TKMS, D-Wave, Novo Nordisk, Siemens Energy, Rheinmetall & Co., DHL, Bayer, Lufthansa, Strategy im Fokus
Top News
DroneShield-Aktie: Leichte Erholung trotz Shortseller-Druck nach Führungsfragen DroneShield-Aktie: Leichte Erholung trotz Shortseller-Druck nach Führungsfragen
BVB-Aktie im Plus: Deutlicher Denkzettel für Watzke nach knapper Wahlbeteiligung BVB-Aktie im Plus: Deutlicher Denkzettel für Watzke nach knapper Wahlbeteiligung
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Alnylam Pharmaceuticals Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
376,40 EUR -2,30 EUR -0,61 %
FSE
440,40 USD -5,26 USD -1,18 %
vorbörslich
BTT
Alnylam Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.50,06 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0CBCK

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS02043Q1076

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolALNY

Alnylam Pharmaceuticals Aktien News

DatumMeistgelesen
BenzingaHere's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years
ZacksIs Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
BenzingaHere's How Much $1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today
Wer­bungAlnylam Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BenzingaWhat Does the Market Think About Alnylam Pharmaceuticals Inc?
BenzingaWhy Is Alnylam Pharmaceuticals Stock Trading Lower Thursday?
ZacksAlnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates
ZacksAlnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
BenzingaPeering Into Alnylam Pharmaceuticals Inc's Recent Short Interest
ZacksAre You Looking for a Top Momentum Pick? Why Alnylam Pharmaceuticals (ALNY) is a Great Choice
ZacksIs the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?
Benzinga$1000 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
ZacksHere's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock
ZacksIs Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
Benzinga27 Analysts Assess Alnylam Pharmaceuticals: What You Need To Know
Benzinga$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
ZacksWhy Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term
BenzingaBeyond The Numbers: 28 Analysts Discuss Alnylam Pharmaceuticals Stock
PR NewswireAlnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
BenzingaHere's How Much $1000 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today
ZacksAre Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?
Benzinga$1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
BenzingaWhere Alnylam Pharmaceuticals Stands With Analysts
BenzingaHere's How Much $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today
BenzingaWhere Alnylam Pharmaceuticals Stands With Analysts
BenzingaDemystifying Alnylam Pharmaceuticals: Insights From 19 Analyst Reviews
BenzingaThis Alnylam Pharmaceuticals Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
BenzingaAlnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast
ZacksAlnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
ZacksAlnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
BenzingaHere's How Much $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today
BenzingaThis Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
BenzingaA Glimpse Into The Expert Outlook On Alnylam Pharmaceuticals Through 10 Analysts
PR NewswireOXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients
PR NewswireOXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients
BenzingaA Glimpse Into The Expert Outlook On Alnylam Pharmaceuticals Through 9 Analysts
BenzingaHere's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years
BenzingaWhat 18 Analyst Ratings Have To Say About Alnylam Pharmaceuticals
BenzingaHere's How Much $1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today
Benzinga$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Benzinga$100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

Alnylam Pharmaceuticals News

Alnylam Pharmaceuticals News: auf dieser Seite finden Sie alle Alnylam Pharmaceuticals News und Nachrichten zur Alnylam Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Alnylam Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Alnylam Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.